An Australian study is set to deliver a world-first model of care to reduce cardiovascular disease in breast cancer survivors.
Cardiovascular disease is Australia’s biggest killer and treatment for breast cancer increases the risk of cardiovascular disease further, yet no formal clinical pathway for prevention, monitoring and management of this risk exists – leading to care that is often fragmented and variable.
Breast cancer is the most commonly diagnosed cancer in Australia, and accounts for more than 13% of all new cancers and 28% of all cancers diagnosed in women.
The two-year study will develop a framework for effective, evidence-based care, where cardiovascular risk management is embedded into breast cancer care to enable breast cancer patients to reduce their risk of cardiovascular disease and access the services they need in a timely manner while coping with the pressures of their cancer treatment.
This product may not be right for you. We recommend that you read the Instruction for Use prior to purchase by clinking on following link: https://mywiwe.com.au/instruction-for-use
IF SYMPTOMS WORSEN OR CHANGE UNEXPECTEDLY, TALK TO YOUR HEALTH PROFESSIONAL. CALL 000 IN AN EMERGENCY.
The WIWE is listed with the Australia Therapeutic Goods Administration (TGA) through our company WIWE Australia as Sponsors. You can view our ARTG Certificate (ARTG Identifier: 294151)